BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35896452)

  • 1. Nonadherence to Clinical Practice Guidelines for Opioid Prescribing in Patients with Chronic Low Back Pain: A Pain Research Registry-Based Study.
    Licciardone JC; Aryal S
    J Am Board Fam Med; 2022; 35(4):724-732. PubMed ID: 35896452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on utilization of nonpharmacological and pharmacological treatments for chronic low back pain and clinical outcomes.
    Licciardone JC
    J Osteopath Med; 2021 Mar; 121(7):625-633. PubMed ID: 33770828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Opioids and Nonsteroidal Anti-Inflammatory Drugs on Chronic Low Back Pain and Related Measures: Results from the PRECISION Pain Research Registry.
    Licciardone JC; Gatchel RJ; Aryal S
    Tex Med; 2018 Oct; 114(10):e1. PubMed ID: 30281768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The process and outcomes of chronic low back pain treatment provided by osteopathic and allopathic physicians: a retrospective cohort study.
    Licciardone JC; Kellerlee J; Joseph M; Mohammad MB; Kim KG; Jain J; Aryal S
    J Osteopath Med; 2023 Aug; 123(8):385-394. PubMed ID: 37225662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopathic Medical Care With and Without Osteopathic Manipulative Treatment in Patients With Chronic Low Back Pain: A Pain Registry-Based Study.
    Licciardone JC; Gatchel RJ
    J Am Osteopath Assoc; 2020 Feb; 120(2):64-73. PubMed ID: 31985765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic management of chronic low back pain: synthesis of the evidence.
    White AP; Arnold PM; Norvell DC; Ecker E; Fehlings MG
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S131-43. PubMed ID: 21952185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, predictors and trends of opioid prescribing for lower back pain in United States emergency departments.
    Walkerly A; Neugebauer RE; Misko B; Shively D; Singh S; Chahda B; Dhanireddy S; King K; Lloyd M; Fosnight S; Costello M; Palladino C; Soric M
    J Clin Pharm Ther; 2021 Jun; 46(3):698-704. PubMed ID: 33314253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids for low back pain.
    Deyo RA; Von Korff M; Duhrkoop D
    BMJ; 2015 Jan; 350():g6380. PubMed ID: 25561513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Nonopioid and Opioid Prescriptions Among Commercially Insured Patients with Chronic Pain.
    Miller GF; Guy GP; Zhang K; Mikosz CA; Xu L
    Pain Med; 2019 Oct; 20(10):1948-1954. PubMed ID: 30481359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomic Analysis of Pain Medications Used to Treat Adult Patients with Chronic Back Pain in the United States.
    Shah D; Anupindi VR; Vaidya V
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):300-307. PubMed ID: 27749151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Opioid Prescribing for Acute Low Back Pain in a Rural Emergency Department.
    Jauregui JE; Nutt RJ; Margolis AM
    Adv Emerg Nurs J; 2020; 42(3):210-214. PubMed ID: 32739950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in the medical treatment of neuropathic low back pain: a Swedish registry-based study of 1.7 million people.
    Nyqvist L; Åkerstedt J; Thoreson O
    BMC Musculoskelet Disord; 2024 Jun; 25(1):486. PubMed ID: 38902709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic low back pain comorbidity count and its impact on exacerbating opioid and non-opioid prescribing behavior.
    Moses-Hampton MK; Povieng B; Ghorayeb JH; Zhang Y; Wu H
    Pain Pract; 2023 Mar; 23(3):252-263. PubMed ID: 36447402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine transdermal system utilization.
    Wallace L; Kadakia A
    Postgrad Med; 2017 Jan; 129(1):81-86. PubMed ID: 27901359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic Characteristics Associated With Utilization of Noninvasive Treatments for Chronic Low Back Pain and Related Clinical Outcomes During the COVID-19 Pandemic in the United States.
    Licciardone JC
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S77-S84. PubMed ID: 33622822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs for chronic low back pain.
    Enthoven WT; Roelofs PD; Deyo RA; van Tulder MW; Koes BW
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD012087. PubMed ID: 26863524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline recommendations on the pharmacological management of non-specific low back pain in primary care - is there a need to change?
    Schreijenberg M; Koes BW; Lin CC
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):145-157. PubMed ID: 30618319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review.
    Tucker HR; Scaff K; McCloud T; Carlomagno K; Daly K; Garcia A; Cook CE
    Br J Sports Med; 2020 Jun; 54(11):664. PubMed ID: 30902816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration].
    Welsch P; Sommer C; Schiltenwolf M; Häuser W
    Schmerz; 2015 Feb; 29(1):85-95. PubMed ID: 25376546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.